We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (7 March 2024) approved the medicine ganaxolone (Ztalmy) as the first anti-seizure medication in the UK to treat cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD).
Treating and disposing of non-hazardous farm waste, sending to landfill, burying waste, incinerating fallen stock and recycling waste fuel oil.
This review compared children given intermittent anti-TB treatment to those given daily treatment
Apply for approval as a facility to treat, recycle or export waste batteries for treatment and recycling and the rules you must follow.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (7 March 2024) approved the medicine rozanolixizumab (Rystiggo) to treat adults with generalised myasthenia gravis, an autoimmune disease that causes muscle weakness, which can affect multiple muscle groups throughout the...
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
The T8 exemption allows you to treat small amounts of waste end-of-life tyres for recovery by baling, shredding, peeling, shaving or granulating.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine etrasimod (Velsipity) to treat people with moderately to severely active ulcerative colitis.
India has responded to the epidemic of multidrug-resistant tuberculosis (MDR-TB) with a number of strategies
You may need to tell DVLA if you have diabetes, depending on the treatment you're getting
Apply to become an approved authorised treatment facility (AATF) and how to operate legally under the approval.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.